Stocksigma LogoStocksigma Logo

Dr. Reddy’s Submits Auditor Review Reports for Q2 FY27 Results

Dr. Reddy’s Laboratories has submitted the Limited Review Reports issued by statutory auditor Deloitte Haskins & Sells LLP for its unaudited standalone and

Dr. Reddy’s Submits Auditor Review Reports for Q2 FY27 Results

Dr Reddys Laboratories Ltd · Others (Uncategorized) · 24 Oct 2026, 4:01 am

Dr. Reddy’s Submits Auditor Review Reports for Q2 FY27 Results Dr. Reddy’s Laboratories has submitted the Limited Review Reports issued by statutory auditor Deloitte Haskins & Sells LLP for its unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The auditor issued an unmodified review conclusion under Regulation 33 of SEBI Listing Regulations, confirming compliance with Ind AS 34 and finding no material misstatements. Key consolidated entities include Aurigene Discovery Technologies, Betapharm Arzneimittel, Dr. Reddy’s Inc., and its newly incorporated Vietnam subsidiary effective 9th May'25.

Original exchange filing (PDF)

More announcements from Dr Reddys Laboratories Ltd

All Dr Reddys Laboratories Ltd announcements